Nexgel (NXGL) Revenue Growth (3y) (2021 - 2025)
Nexgel (NXGL) Revenue Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.77% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -0.75% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.62% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 5.64% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 7.22% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.32% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.43% |
| 10 | Nexgel | 4.18 Mn | 2.81 Mn | 819,000.00 | 74.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.74% |
| Sep 30, 2025 | 72.86% |
| Jun 30, 2025 | 72.59% |
| Mar 31, 2025 | 92.07% |
| Dec 31, 2024 | 78.69% |
| Sep 30, 2024 | 106.27% |
| Jun 30, 2024 | 51.15% |
| Mar 31, 2024 | 68.00% |
| Dec 31, 2023 | 120.45% |
| Sep 30, 2023 | 71.51% |
| Jun 30, 2023 | 134.07% |
| Mar 31, 2023 | 37.21% |
| Dec 31, 2022 | 43.86% |
| Sep 30, 2022 | 25.55% |
| Mar 31, 2022 | 45.33% |
| Dec 31, 2021 | 4.96% |
| Sep 30, 2021 | -1.26% |